Klinikum rechts der Isar der Technischen Universität München

München, Bavaria 81675

0 studies enrolling now · 6 studies all time

What they study most

Advanced Cholangiocarcinoma, Alzheimer's Disease, Breast Cancer, Cholangiocarcinoma, FGFR2 Gene Mutation, HCC, Hepatocellular Carcinoma, Liver Cancer, Metastatic Melanoma

Studies at this site

• A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib — Completed
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma — Completed
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed